Trial intelligence / Profile preview

Comparison of Injection Techniques for Adhesive Capsulitis

NCT07364227Not yet recruiting

Sponsor
Aslınur Keleş Ercişli
Start
Jan 2026
Primary completion
May 2026
Modality
Small Molecules
01

Overview

Randomised trial of lidocaine in adhesive capsulitis (AC) (3 arms), sponsored by Aslınur Keleş Ercişli. Primary endpoint: Range of Motion at 12 weeks. Planned start Jan 2026; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

adhesive capsulitis (AC)

Beyond the preview

Go deeper on NCT07364227.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07364227.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call